Endophthalmitis following intravitreal anti-VEGF injections in ambulatory surgical centre facility: Incidence, management and outcome

British Journal of Ophthalmology

Volumn 97, Issue 12, 2013, Pages 1609-1612

  Mithal, Kopal ^a   Mathai, Annie ^a   Pathengay, Avinash ^a   Jalali, Subhadra ^a   Relhan, Nidhi ^a   Motukupally, Swapna Reddy ^a   Sharma, Savitri ^a   Das, Taraprasad ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; CEFTAZIDIME; DEXAMETHASONE; PEGAPTANIB; RANIBIZUMAB; VANCOMYCIN; VASCULOTROPIN ANTIBODY;

BACTERIUM DETECTION; BACTERIUM ISOLATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG RESPONSE; ENDOPHTHALMITIS; EPIDEMIC; HUMAN; INCIDENCE; LETTER; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETREATMENT; RETROSPECTIVE STUDY; STAPHYLOCOCCUS HOMINIS; STREPTOCOCCUS SANGUINIS; TREATMENT DURATION; VISUAL ACUITY; VITRECTOMY; VITREOUS BIOPSY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; ENDOPHTHALMITIS; FEMALE; HUMANS; INCIDENCE; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84888641567     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2013-303222     Document Type: Letter

References (5)

1. McCannelcolin A. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative agents and possible preventive strategies. Retina 2011;31:654 -61.
2. Gonzalez S, Rosenfeld PJ, Stewart MW, et al. Perspective: avastin doesn't blind people, people blind people. Am J Ophthalmol 2012;153:196-203.
3. Simunovic MP, Rush RB, Hunyor AP, et al. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol 2012;96:862-6.
4. Abell RG, Kerr NM, Allen P, et al. Intravitreal injections: is there benefit for theatre settings? Br J Ophthalmol 2012;96:1474-8.
5. Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr, et al. Endophthalmitis after intravitreal anti-vascular endothelial growth factor antagonists: a six year experience at a university referral centre. Retina 2011;31:662-8.